Origin Therapeutics Holdings (XCNQ:ORIG) Price-to-Tangible-Book : 0.46 (As of Jun. 09, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Price-to-Tangible-Book?

As of today (2024-06-09), Origin Therapeutics Holdings's share price is C$0.025. Origin Therapeutics Holdings's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was C$0.05. Hence, Origin Therapeutics Holdings's Price to Tangible Book Ratio of today is 0.46.

The historical rank and industry rank for Origin Therapeutics Holdings's Price-to-Tangible-Book or its related term are showing as below:

XCNQ:ORIG' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.21 Med: 0.46 Max: 0.71
Current: 0.5

During the past 2 years, Origin Therapeutics Holdings's highest Price to Tangible Book Ratio was 0.71. The lowest was 0.21. And the median was 0.46.

XCNQ:ORIG's Price-to-Tangible-Book is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.265 vs XCNQ:ORIG: 0.50

A closely related ratio is called PB Ratio. As of today, Origin Therapeutics Holdings's share price is C$0.025. Origin Therapeutics Holdings's Book Value per Sharefor the quarter that ended in Jun. 2023 was C$0.05. Hence, Origin Therapeutics Holdings's P/B Ratio of today is 0.46.

Origin Therapeutics Holdings Price-to-Tangible-Book Historical Data

The historical data trend for Origin Therapeutics Holdings's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Price-to-Tangible-Book Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Price-to-Tangible-Book

0.47

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Price-to-Tangible-Book	Get a 7-Day Free Trial				0.71	0.47	0.21	0.45	0.46

Competitive Comparison of Origin Therapeutics Holdings's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Origin Therapeutics Holdings's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Origin Therapeutics Holdings's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Origin Therapeutics Holdings's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Origin Therapeutics Holdings's Price-to-Tangible-Book falls into.

Origin Therapeutics Holdings Price-to-Tangible-Book Calculation

Origin Therapeutics Holdings's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2023 )
	=	0.025	/	0.054
	=	0.46

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Origin Therapeutics Holdings Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.